Bromday Versus Nevanac Eye Drops to Control Pain Following Photorefractive Keratectomy

Completed

Conditions studied: Myopia

In brief

This study will compare the effect of two topical non-steroidal antiinflammatory agents to control pain after photorefractive keratectomy (PRK) eye surgery.

Key facts

Study ID

NCT01475877

Run by

Virdi Eye Clinic

People needed

20

Starts

2011-05-01

Expected to finish

2012-05-01

Last updated by the study team

2016-05-03

Who can join

Age: 21 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• male or female at least 18 years of age,
• no other ocular studies with 15 days prior to dosing,
• BCVA 20/200 or better,
• return for study visits and follow instructions from investigator and staff,
• self administer test article

You may not qualify if…

• Ocular inflammation,
• hypersensitivity to bromfenac or nepafenac,
• any corneal pathology,
• have had radial keratotomy,
• corneal transplant or corneal refractive surgery in the last two years

Where it is running

• Virdi Eye Clinic and Laser Vision Center — Rock Island, Illinois, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.